前收盘价格 | 0.410 |
收盘价格 | 0.410 |
成交量 | 1,543,200 |
平均成交量 (3个月) | 578,410 |
市值 | 653,847,424 |
市盈率 (P/E TTM) | 39.50 |
预期市盈率 (P/E Forward) | 5.98 |
价格/销量 (P/S) | 0.120 |
股市价格/股市净资产 (P/B) | 2.13 |
52周波幅 | |
利润日期 | 28 Aug 2025 - 1 Sep 2025 |
营业毛利率 | 0.43% |
营业利益率 (TTM) | 1.65% |
稀释每股收益 (EPS TTM) | 0.010 |
季度收入增长率 (YOY) | 28.40% |
季度盈利增长率 (YOY) | 85.80% |
总债务/股东权益 (D/E MRQ) | 96.44% |
流动比率 (MRQ) | 1.02 |
营业现金流 (OCF TTM) | 22.78 M |
杠杆自由现金流 (LFCF TTM) | 1.74 M |
资产报酬率 (ROA TTM) | 3.12% |
股东权益报酬率 (ROE TTM) | 4.74% |
市场趋势
短期 | 中期 | ||
行业 | Medical Distribution (AU) | 混合的 | 混合的 |
Medical Distribution (全球的) | 看跌 | 看跌 | |
股票 | PARAGON FPO [PGC] | - | - |
AIStockmoo 评分
0.4
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | 4.5 |
技术平均移动指标 | -1.0 |
技术振荡指标 | -2.0 |
平均 | 0.38 |
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market. |
|
部门 | Healthcare |
行业 | Medical Distribution |
投资方式 | Small Core |
内部持股比例 | 69.89% |
机构持股比例 | 10.58% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合